Literature DB >> 21081607

What makes an orphan drug?

Nigel Hawkes1, Deborah Cohen.   

Abstract

Mesh：

Year:  2010        PMID： 21081607     DOI： 10.1136/bmj.c6459

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  [Rare diseases: laying out some challenges].

Authors: 
Journal:  Cambios Rev Med       Date:  2017-01

2.  Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU.

Authors:  Roberta Joppi; Vittorio Bertele'; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

Review 3.  Effectiveness, safety and costs of orphan drugs: an evidence-based review.

Authors:  Igho J Onakpoya; Elizabeth A Spencer; Matthew J Thompson; Carl J Heneghan
Journal:  BMJ Open       Date:  2015-06-24       Impact factor: 2.692

4.  Application of orphan drug designation to cancer treatments (2008-2017): a comprehensive and comparative analysis of the USA and EU.

Authors:  Kerstin Noëlle Vokinger; Aaron S Kesselheim
Journal:  BMJ Open       Date:  2019-10-10       Impact factor: 2.692

5.  Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017.

Authors:  Cara Usher; Laura McCullagh; Lesley Tilson; Michael Barry
Journal:  Pharmacoecon Open       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.